Immunology Applications
Immune cell interactions and therapeutic efficacy (e.g., CAR-T)
ResearchActive
Key Facts
Indication
Immune cell interactions and therapeutic efficacy (e.g., CAR-T)
Phase
Research
Status
Active
Company
About Cellanome
Founded in 2020, Cellanome is a private, platform-technology company operating in the genetics and genomics sector. Its core innovation is the Cellanome R3200 Platform, an integrated system that combines live-cell imaging, single-cell transcriptomics, and programmable micro-environments (CellCages) to track cellular dynamics and interactions longitudinally. The company is pre-revenue, targeting research applications in immunology, oncology, neurobiology, and aging to accelerate therapeutic discovery and biological modeling.
View full company profile